🇺🇸 FDA
Patent

US 9029321

Methods and compositions for targeting adipose cells in mammals

granted A61KA61K38/00A61K38/10

Quick answer

US patent 9029321 (Methods and compositions for targeting adipose cells in mammals) held by The Board of Regents of the University of Texas expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas
Grant date
Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61K38/10, A61K47/64, A61P